Showing results (11-20 of 99) with videos related to
Sort By:
Pageof 10
Medical Mycology|February 13, 1999
Antifungal drug resistance in pathogenic fungiH Vanden Bossche, F Dromer, I Improvisi, et al.Antimicrobial Agents and Chemotherapy|February 27, 1999
Treatment of murine fusariosis with SCH 56592M Lozano-Chiu, S Arikan, V L Paetznick, et al.Antimicrobial Agents and Chemotherapy|February 4, 1998
Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasisJ H Rex, P W Nelson, V L Paetznick, et al.Journal of Clinical Microbiology|August 15, 1998
Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testingM A Pfaller, S Arikan, M Lozano-Chiu, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2001
Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infectionsE J Anaissie, R T Kuchar, J H Rex, et al.Infection and Immunity|March 1, 1976
Preparative isotachophoretic separation of skin test antigens from blastomycin purified derivativeM V Lancaster, R F SprouseInfection and Immunity|September 1, 1976
Isolation of a purified skin test antigen from Blastomyces dermatitidis yeast-phase cell wallM V Lancaster, R F SprouseEuropean Journal of Clinical Microbiology|August 1, 1984
Spectral analysis of biochemical reactions used for identification of bacteriaA E Hilger, M V LancasterCurrent Pharmaceutical Design|March 20, 2001
Lipid-based antifungal agents: current statusS Arikan, J H RexCurrent Opinion in Investigational Drugs (London, England : 2000)|September 22, 2001
Nystatin LF (Aronex/Abbott)S Arikan, J H RexPageof 10